Merck prevails in patent lawsuit involving sitagliptin phosphate in US court
The US District Court found both Merck patents regarding sitagliptin to be valid and infringed
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
26 Sep 22
The US District Court found both Merck patents regarding sitagliptin to be valid and infringed
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
23 Sep 22
GSK will obtain exclusive rights to develop and market Tebipenem HBr worldwide, excluding Japan and certain other Asian…
23 Sep 22
The patient dosing with the haemophilia A gene therapy candidate is expected to start in October 2022 in…
22 Sep 22
Parker's Plant Based Foods' Quad Protein Smoothie is manufactured in a peanut-free facility and is non-GMO, vegan, and…
22 Sep 22
The product line consists of four non-alcoholic spirits and two aperitifs, all of which are available to US…
22 Sep 22
"Steve's upcoming panel at the Kroger Wellness Festival gives us a unique opportunity to showcase the role that…
22 Sep 22
Texas leads the growing movement of hemp-derived, Farm Bill-Compliant THC beverages, and the 8th Wonder and Bayou City Hemp partnership…
22 Sep 22
Retevmo is an oral, selective RET kinase inhibitor, indicated for locally advanced or metastatic solid tumours with a…
22 Sep 22
The pilot project brings together expertise in biopharma and technology to improve regional health interventions and expedite the…
21 Sep 22
The transaction, which has been unanimously approved by the boards of directors of both the companies, is expected…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates